Molecular modeling of lysophosphatidic acid receptor antagonists.

被引：0
|
作者：
Sardar, VM
Virag, T
Fischer, DJ
Elrod, D
Bautista, DL
Wang, DA
Nusser, N
Yokoyama, K
Baker, DL
Miller, DD
Tigyi, G
Parrill, AL
机构：
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
[2] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA
[3] Univ Tennessee, Dept Physiol & Biophys, Knoxville, TN 37996 USA
[4] Univ Tennessee, Dept Pharmaceut Sci, Knoxville, TN 37996 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
079-MEDI
引用
收藏
页码：U19 / U19
页数：1
相关论文
共 50 条
  • [1] Search for selective lysophosphatidic acid (LPA) antagonists.
    Miller, DD
    Sardar, VM
    Elrod, D
    Sun, GP
    Xu, HP
    Dalton, JT
    Tigyi, G
    Baker, D
    Virag, T
    Nusser, N
    Fischer, D
    Lörincz, Z
    Jennings, L
    Bao, JX
    Parrill, AL
    Bautista, D
    Liliom, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U594 - U594
  • [2] Synthesis and biological evaluation of lysophosphatidic acid (LPA) antagonists.
    Heasley, BH
    Macdonald, TL
    Lynch, KR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U218 - U218
  • [3] Structure-activity relationships of lysophosphatidic acid: Synthesis and analysis of Edg receptor agonists and antagonists.
    Santos, WL
    Heise, CE
    Lynch, KR
    Macdonald, TL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U687 - U687
  • [4] Lysophosphatidic acid receptor agonists and antagonists (WO2010051053)
    Parrill, Abby L.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (02) : 281 - 286
  • [5] Novel adenosine all receptor antagonists.
    Petter, RC
    Kiesman, WF
    Conlon, PR
    Kumaravel, G
    Ensinger, CL
    Dowling, J
    Peng, B
    Smits, G
    Jin, XW
    Lutterodt, FA
    Fu, K
    LePage, D
    Jayaraj, A
    Gill, A
    Costa, D
    Wortham, K
    Porter, K
    Linden, J
    Sullivan, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U79 - U79
  • [6] Diarylamidines and -imidazolines as NMDA receptor antagonists.
    Zhang, Q
    Huang, TL
    Sharma, TA
    Reynolds, IJ
    Donkor, IO
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U234 - U234
  • [7] Cyclic peptides as VEGF receptor antagonists.
    Goncalves, V.
    Gautier, B.
    Garbay, C.
    Vidal, M.
    Inguimbert, N.
    BIOPOLYMERS, 2007, 88 (04) : 541 - 541
  • [8] MOLECULAR MODELING OF ADENOSINE RECEPTOR ANTAGONISTS
    VANGALEN, PJM
    VANVLIJMEN, HWT
    IJZERMAN, AP
    SOUDIJN, W
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (06) : 339 - 339
  • [9] Molecular cloning of a novel lysophosphatidic acid receptor.
    Im, DS
    Hönneman, CW
    Hooks, SB
    Hopper, DW
    Durieux, ME
    Marchese, A
    George, SR
    O'Dowd, BF
    Macdonald, TL
    Lynch, KR
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R657 - R657
  • [10] Molecular basis for lysophosphatidic acid receptor antagonist selectivity
    Sardar, VM
    Bautista, DL
    Fischer, DJ
    Yokoyama, K
    Nusser, N
    Virag, T
    Wang, DA
    Baker, DL
    Tigyi, G
    Parrill, AL
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3): : 309 - 317
12345